Contribution Framing (jppm-contribution-framing)
When to trigger
- The Policy Contribution Statement draft is generic or missing one of its three required elements
- The implications section says "policymakers should consider" and stops
- Findings are solid but you cannot connect them to a decision anyone faces
- The paper drifts into recommending policies the data never tested
- Reviewers might read the framing as advocacy rather than evidence
The Policy Contribution Statement is the contribution
JPP&M requires every submission to open the main document with a Policy Contribution Statement of at most 300 words (it does not count against the 50-page cap). It must do three things, per the journal's guidelines: (1) name the policy conversation the paper initiates or joins; (2) state how the manuscript moves understanding beyond the existing marketing-and-public-policy literature; (3) identify which specific policy stakeholders are affected and how. Treat this statement as the paper's thesis, not an administrative form — editors use it for desk-screening and reviewers read it first. If the statement cannot be written crisply, the problem is upstream (fit or evidence), not wording.
A working shape: "Agencies X and Y are currently deciding D. Existing work establishes A but cannot tell them B. Using [design], we show E [magnitude, for whom]. This implies stakeholder X should [specific action within its authority], while marketers subject to the rule should [specific response]."
The actionability test
For each implication, ask four questions; all must pass:
- Named actor — a specific body (FTC, FDA, CFPB, USDA, state AGs, a self-regulatory program like CARU/NAD, an NGO, or firms facing the rule), not "policymakers."
- Within authority — the action lies inside that actor's legal instruments. Recommending the FTC set nutrition standards, or the FDA police deceptive pricing, signals the authors don't know the terrain.
- Evidence-linked — the recommended choice is one the paper's contrasts or estimates actually inform. If you tested icon vs. text warnings, you can advise on format — not on whether warnings beat taxes.
- Concrete enough to implement or reject — a reader at the agency could put it into a rule, guidance, enforcement priority, or comment letter tomorrow.
Marketers are stakeholders too: what should a compliant firm change in labeling, targeting, data practice, or claims substantiation? A JPP&M implication set that speaks to both the regulator and the regulated is stronger than one that lectures only the agency.
Evidence, not advocacy
JPP&M welcomes normatively motivated questions but punishes advocacy untethered from results. Discipline the frame: report what the intervention does and does not achieve; keep recommendation strength proportional to identification strength (a lab study "suggests"; a well-identified evaluation "shows"); surface the trade-offs (costs to firms, burden on consumers, speech concerns) even when they cut against the preferred conclusion. Papers that acknowledge the strongest counterargument to their own implication read as trustworthy; papers that hide it read as briefs.
Calibrating claims to evidence
- Scope: bound the claim to the tested population, product category, and format; flag the extrapolation needed to reach the policy scale.
- Magnitude honesty: lead with the decision-unit effect and its CI, not with the significance.
- Null and backfire results are contributions: "the mandated format does not help, and here is why" is publishable and policy-critical here — do not bury it.
- One primary implication: a single well-defended recommendation beats a scattershot list of six.
Checklist
Anti-patterns
- The bolted-on paragraph: a consumer study with policy vocabulary appended in the discussion — JPP&M's signature desk reject
- Ghost-actor implications: advice addressed to "policymakers" or "society"
- Authority errors: recommendations outside the named agency's legal instruments
- Advocacy leakage: recommendation strength driven by conviction rather than estimates
- Implication inflation: six recommendations from one manipulation
- Buried backfire: an unintended consequence found in the data but absent from the statement
Output format
【Policy Contribution Statement】conversation / advance / stakeholders (≤300 words, drafted)
【Primary implication】named actor + instrument + specific action
【Marketer-facing implication】what regulated firms should change
【Evidence link】which estimate licenses each recommendation
【Trade-offs stated】costs, burdens, counterargument acknowledged? [Y/N]
【Next skill】jppm-tables-figures
Source: brycewang-stanford/Awesome-Journal-Skills → Journal-of-Public-Policy-and-Marketing-Skills/skills/jppm-contribution-framing/SKILL.md
1---2name: jppm-contribution-framing3description: Use when sharpening the policy contribution of a Journal of Public Policy & Marketing (JPP&M) manuscript — the 300-word Policy Contribution Statement, regulator-actionable implications, and the line between evidence and advocacy. Frames the contribution; it does not produce the estimates (jppm-data-analysis).4---567# Contribution Framing (jppm-contribution-framing)89## When to trigger1011- The Policy Contribution Statement draft is generic or missing one of its three required elements12- The implications section says "policymakers should consider" and stops13- Findings are solid but you cannot connect them to a decision anyone faces14- The paper drifts into recommending policies the data never tested15- Reviewers might read the framing as advocacy rather than evidence1617## The Policy Contribution Statement is the contribution1819JPP&M requires every submission to open the main document with a **Policy Contribution Statement of at most 300 words** (it does not count against the 50-page cap). It must do three things, per the journal's guidelines: (1) name the **policy conversation** the paper initiates or joins; (2) state how the manuscript **moves understanding beyond** the existing marketing-and-public-policy literature; (3) identify **which specific policy stakeholders** are affected and **how**. Treat this statement as the paper's thesis, not an administrative form — editors use it for desk-screening and reviewers read it first. If the statement cannot be written crisply, the problem is upstream (fit or evidence), not wording.2021A working shape: *"Agencies X and Y are currently deciding D. Existing work establishes A but cannot tell them B. Using [design], we show E [magnitude, for whom]. This implies stakeholder X should [specific action within its authority], while marketers subject to the rule should [specific response]."*2223## The actionability test2425For each implication, ask four questions; all must pass:26271. **Named actor** — a specific body (FTC, FDA, CFPB, USDA, state AGs, a self-regulatory program like CARU/NAD, an NGO, or firms facing the rule), not "policymakers."282. **Within authority** — the action lies inside that actor's legal instruments. Recommending the FTC set nutrition standards, or the FDA police deceptive pricing, signals the authors don't know the terrain.293. **Evidence-linked** — the recommended choice is one the paper's contrasts or estimates actually inform. If you tested icon vs. text warnings, you can advise on format — not on whether warnings beat taxes.304. **Concrete enough to implement or reject** — a reader at the agency could put it into a rule, guidance, enforcement priority, or comment letter tomorrow.3132Marketers are stakeholders too: what should a compliant firm change in labeling, targeting, data practice, or claims substantiation? A JPP&M implication set that speaks to both the regulator and the regulated is stronger than one that lectures only the agency.3334## Evidence, not advocacy3536JPP&M welcomes normatively motivated questions but punishes advocacy untethered from results. Discipline the frame: report what the intervention does *and does not* achieve; keep recommendation strength proportional to identification strength (a lab study "suggests"; a well-identified evaluation "shows"); surface the trade-offs (costs to firms, burden on consumers, speech concerns) even when they cut against the preferred conclusion. Papers that acknowledge the strongest counterargument to their own implication read as trustworthy; papers that hide it read as briefs.3738## Calibrating claims to evidence3940- **Scope**: bound the claim to the tested population, product category, and format; flag the extrapolation needed to reach the policy scale.41- **Magnitude honesty**: lead with the decision-unit effect and its CI, not with the significance.42- **Null and backfire results are contributions**: "the mandated format does not help, and here is why" is publishable and policy-critical here — do not bury it.43- **One primary implication**: a single well-defended recommendation beats a scattershot list of six.4445## Checklist4647- [ ] Policy Contribution Statement ≤300 words, covering conversation / advance / stakeholders48- [ ] Every implication names an actor, sits within its authority, and is evidence-linked49- [ ] Implications address both regulator and regulated marketers where relevant50- [ ] Recommendation strength matches identification strength51- [ ] Trade-offs and the strongest counterargument are stated52- [ ] Nulls, boundary conditions, and unintended effects appear in the framing, not the footnotes5354## Anti-patterns5556- **The bolted-on paragraph**: a consumer study with policy vocabulary appended in the discussion — JPP&M's signature desk reject57- **Ghost-actor implications**: advice addressed to "policymakers" or "society"58- **Authority errors**: recommendations outside the named agency's legal instruments59- **Advocacy leakage**: recommendation strength driven by conviction rather than estimates60- **Implication inflation**: six recommendations from one manipulation61- **Buried backfire**: an unintended consequence found in the data but absent from the statement6263## Output format6465```text66【Policy Contribution Statement】conversation / advance / stakeholders (≤300 words, drafted)67【Primary implication】named actor + instrument + specific action68【Marketer-facing implication】what regulated firms should change69【Evidence link】which estimate licenses each recommendation70【Trade-offs stated】costs, burdens, counterargument acknowledged? [Y/N]71【Next skill】jppm-tables-figures72```7374---7576**Source:** [`brycewang-stanford/Awesome-Journal-Skills`](https://github.com/brycewang-stanford/Awesome-Journal-Skills) → `Journal-of-Public-Policy-and-Marketing-Skills/skills/jppm-contribution-framing/SKILL.md`